Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65,276
Closed -$994K 1024
2022
Q4
$994K Sell
65,276
-23,290
-26% -$332K ﹤0.01% 830
2022
Q3
$1.24M Buy
88,566
+8,495
+11% +$171K 0.01% 890
2022
Q2
$1.93M Buy
80,071
+14,453
+22% +$388K 0.01% 848
2022
Q1
$2.02M Buy
65,618
+5,460
+9% +$196K 0.01% 850
2021
Q4
$2.73M Buy
60,158
+21,152
+54% +$905K 0.01% 726
2021
Q3
$1.69M Buy
+39,006
New +$1.7M 0.01% 801
2021
Q2
Sell
-27,956
Closed -$1.24M 942
2021
Q1
$1.24M Sell
27,956
-4,118
-13% -$173K 0.01% 782
2020
Q4
$1.27M Sell
32,074
-25,998
-45% -$966K 0.01% 823
2020
Q3
$2.27M Sell
58,072
-2,662
-4% -$102K 0.01% 709
2020
Q2
$2.36M Sell
60,734
-53,654
-47% -$1.81M 0.01% 609
2020
Q1
$3.83M Buy
114,388
+55,450
+94% +$1.82M 0.03% 483
2019
Q4
$1.92M Buy
+58,938
New +$1.94M 0.01% 759

Other funds holding NEOG

Aviva's NEOG Position: Q1 2023 in Review

Aviva sold out of Neogen (NEOG) in Q1 2023, closing a stake of 65,276 shares — an estimated $994K sold.

Aviva first reported a position in NEOG in Q4 2019 and held it in 12 quarters. The position peaked at $3.83M in Q1 2020. 354 funds tracked by Wall St. Rank hold NEOG as of Q1 2023.

  • Aviva reported no remaining Neogen position as of Q1 2023 after selling out during the quarter.
  • Aviva sold 65,276 Neogen shares in Q1 2023, an estimated $994K.
  • Aviva first reported a position in Neogen in Q4 2019 and held it in 12 quarters.
  • Aviva's Neogen position peaked at $3.83M in Q1 2020.
  • 354 funds tracked by Wall St. Rank held Neogen as of Q1 2023.

Based on Aviva's 13F filing for Q1 2023, filed 12 May 2023.